Thomas W. Greeson[email protected]Practice ManagementWhat awaits radiologists when the public health emergency ends?During the COVID-19 public health emergency (PHE), the U.S. Centers for Medicare Services amended or waived a number of rules that affected radiologists. Attorney Thomas W. Greeson of Reed Smith discusses how the expected end of the PHE will affect radiologists.April 10, 2022Page 1 of 1Top StoriesCTCT muscle metrics could help screen for sarcopeniaAbdominal CT muscle metrics taken from imaging of healthy young people show promise for opportunistic sarcopenia screening.Womens ImagingCancer incidence on rise in younger people, womenAssociationsFinancial shock waves strike close to radiology researchersMRICNN techniques outperform conventional DL for Alzheimer's diagnosisWomens ImagingAbout half of women undecided on AI's use in breast imaging
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
